scholarly journals Clinical progression of COVID-19 coinfection in people living with the human immunodeficiency virus: scoping review

2022 ◽  
Vol 75 (2) ◽  
Author(s):  
Diego Schaurich ◽  
Oclaris Lopes Munhoz ◽  
Angelo Ramos Junior ◽  
Angelica Dalmolin ◽  
Gabriela Oliveira ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Scoping Review ◽  
Web Of Science ◽  
Data Extraction ◽  
Clinical Manifestations ◽  
Supplemental Oxygen ◽  
Narrative Synthesis ◽  
Clinical Progression ◽  
Immunodeficiency Virus ◽  
Worse Prognosis

ABSTRACT Objectives: to map the production of scientific knowledge on the clinical progression of COVID-19 coinfection in people living with the human immunodeficiency virus (HIV). Methods: scoping review, with search strategies in MEDLINE, Scopus, Embase, Web of Science, and LILACS. Dual independent data extraction and analysis of the material with similarity compilation and narrative synthesis. Results: sample consisted of 35 articles. Fever, cough, and dyspnea were the most prevalent signs/symptoms. Recurrent complications involved desaturation/worsening of oxygen desaturation and pneumonia. No standard pharmacological treatment was identified, and the main interventions involved the provision of supplemental oxygen and mechanical ventilation. The studies recommended preventive, care, and pharmacological practices. Conclusions: the clinical manifestations, complications, and treatments/assistance care for people coinfected with SARS CoV-2/HIV are similar to those of the general population. Coinfection, overall, does not infer a worse prognosis.

Human immunodeficiency virus detection: correlation with clinical progression in the Edinburgh haemophiliac cohort

1989 ◽  
Vol 72 (3) ◽  
pp. 387-390 ◽  
Author(s):  
R. J. G. Cuthbert ◽  
C. A. Ludlam ◽  
Selma Rebus ◽  
J. F. Peutherer ◽  
D. W. J. Aw ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Virus Detection ◽  
Clinical Progression ◽  
Immunodeficiency Virus

scholarly journals Prevalence of human immunodeficiency virus infection among primigravida, in Karnataka

2018 ◽  
Vol 5 (12) ◽  
pp. 5448
Author(s):  
Vani Srinivas ◽  
T. L. N. Prasad ◽  
Rajesh T. Patil ◽  
Sunil D. Khaparde
Keyword(s):  
Human Immunodeficiency Virus ◽  
General Population ◽  
Pregnant Women ◽  
Data Extraction ◽  
Demographic Data ◽  
Striking Difference ◽  
Hiv Status ◽  
Cross Sectional ◽  
Immunodeficiency Virus ◽  
The Difference

Background: Karnataka is one of the six high human immunodeficiency virus (HIV) prevalent states in India. We estimated prevalence among primigravida attending antenatal clinics in Karnataka, assuming this as a proxy for HIV incidence level in the general population.Methods: We tried estimating prevalence among primigravida using cross sectional samples. Data was collected in structured data extraction sheet for the month of September 2011, from all Integrated and Counselling tested Centres (ICTCs) of Karnataka. All the pregnant women were tested as per national protocol. We analysed the basic demographic data, geographical distribution including HIV status of spouse of primigravida.Results: In September 2011, 87580, pregnant women were tested and 238 (0.26%) were found HIV positive of which, 95 (40%) were primigravida. Prevalence among primigravida, was 0.3%. The prevalence among primigravida was highest in Bagalkot (1.6%) district. In Yadgir, Kodagu and Udupi the prevalence was zero. The high prevalent blocks were Jamakhandi, Mudhol, Gokak, Hospet and Muddebihal. 73.7% spouse of positive primigravida were tested for HIV and among those tested, 87.1% were found HIV positive.Conclusions: There is striking difference in the prevalence of HIV among primigravida in different districts of Karnataka probably indicates the difference in effectiveness of preventive interventions in these districts and within blocks. The preventive programs should be reached out to the labourer's and farmers in the general population to prevent the new infections in the general population.

CORRELATION OF CLINICAL PROGRESSION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN WITH IN VITRO ZIDOVUDINE RESISTANCE BY A DIRECT QUANTITATIVE PERIPHERAL BLOOD LYMPHOCYTE ASSAY

PEDIATRICS ◽  
1996 ◽  
Vol 98 (2) ◽  
pp. 346-346
Author(s):  
Jan P. Sinclair ◽  
I. Celine Hanson
Keyword(s):  
Human Immunodeficiency Virus ◽  
Antiretroviral Therapy ◽  
Early Identification ◽  
Blood Lymphocyte ◽  
Clinical Progression ◽  
Current Standard ◽  
Enhanced Sensitivity ◽  
Immunodeficiency Virus ◽  
Azt Resistance

The DQPBL assay has a number of advantages over the consensus ACTG assay, being faster and less costly. The reliability of the DQPBL in comparison to the current standard is demonstrated (67% concordance, 29% enhanced sensitivity and 5% discordance). In this study, there was a correlation between AZT resistance and disease progression requiring change in antiretroviral therapy. Whether early identification of resistance to AZT will enable timely change in antiretroviral therapy, and slowing of clinical and immunologic deterioration remains to be demonstrated.

Chronic Kidney Disease in Cameroon: A scoping review

2020 ◽  
Author(s):  
Jerry Brown Aseneh ◽  
Ben-Lawrence A. Kemah ◽  
Stephane Mabouna ◽  
Njang Mbeng Emmanuel ◽  
Domin Sone Majunda Ekane ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Chronic Kidney Disease ◽  
Human Immunodeficiency Virus ◽  
Kidney Disease ◽  
Scoping Review ◽  
Associated Factors ◽  
Treatment Cost ◽  
Advanced Age ◽  
High Morbidity ◽  
Immunodeficiency Virus

Abstract ObjectivesThis scoping review sought to summarize available data on the prevalence, associated factors, etiology, comorbidities, treatment, cost, and mortality of chronic kidney disease (CKD) in Cameroon.MethodsWe searched PubMed, Scopus and African Journals Online from database inception to 31 March, 2020 to identify all studies published on the prevalence, associated factors, etiology, comorbidities, treatment, cost and mortality of CKD in Cameroon.ResultsThirty studies were included. The population prevalence of CKD varied from 3-14.1% and 10.0%-14.2% in rural and urban areas, respectively. The prevalence of CKD in patients with hypertension, diabetes mellitus, and human immunodeficiency virus was 12.4-50.0%, 18.5%, and 3.0-47.2%, respectively. Hypertension (22.3-59.1%), chronic glomerulonephritis (15.8-56.2%), and diabetes mellitus (15.8-56.2%) were the most common causes of CKD. The cause was unknown in 13.5-17.0% of the cases. Advanced age, hypertension, diabetes mellitus, and obesity were frequent associated factors. Hemodialysis was the main treatment modality in patients with End Stage Renal Disease (ESRD). The monthly cost of management of non-dialyzed CKD was 163 US dollars. The one-year mortality rate of ESRD was 26.8-38.6%.ConclusionChronic kidney disease in affects about one in ten adults in the general population in Cameroon Patients with hypertension, diabetes mellitus, and human immunodeficiency virus bear the greatest burden of CKD in Cameroon. Advanced age, hypertension, diabetes mellitus, and obesity are major factors associated with CKD. Chronic kidney disease in Cameroon is associated with high morbidity and mortality and huge economic cost on the patient.

scholarly journals Coinfection and delayed diagnosis of visceral leishmaniasis: Died predecessors factors

2019 ◽  
Vol 6 (1) ◽  
pp. 19
Author(s):  
Jaciel de Oliveira Clementino ◽  
Daniel Gallina Martins Abrahão ◽  
Manoel Sebastião Da Costa Lima Junior ◽  
Herintha Coeto Neitzke Abreu
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Septic Shock ◽  
Human Immunodeficiency Virus ◽  
Visceral Leishmaniasis ◽  
Leishmania Infantum ◽  
Delayed Diagnosis ◽  
Clinical Manifestations ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Immunodeficiency Virus

Visceral leishmaniasis (VL) is an anthropozoonosis caused by Leishmania infantum in most Brazilian states and is known for its significant lethality resulting from improper diagnosis and treatment. VL is difficult to diagnose because its clinical manifestations and laboratory abnormalities are analogous to several other pathologies. We report a case of a 54-year-old man, negative for Human Immunodeficiency Virus (HIV), with VL who was initially diagnosed with anemia, consumptive syndrome, pneumonia, chronic obstructive pulmonary disease, and septic shock and died due to a delayed diagnosis of VL. 

Sign in / Sign up

Export Citation Format

Share Document